Spirit Scientific biotech Expands Globally, Shines at Tokyo and BIO Asia Expos
Spirit Scientific biotech, a company focused on standardized regenerative medicine, showcased its innovative BMLT® at 2 major expos: the Regenerative Medicine Expo TOKYO and the upcoming BIO Asia-Taiwan.
The company’s core technology allows it to transform biological materials into stable, precise, and easy-to-use lyophilized products like Platelet Lyophilized Treatment(PLT).
This offers a major advantage over traditional therapies like PRP, which can be inconsistent.
With over 36,000 cases in Taiwan and a newly opened lab in Japan, Spirit Scientific biotech is expanding its global reach.
The company is actively seeking international partners to help scale its “Biofoundry™” platform, which aims to standardize and improve the efficiency of regenerative medicine worldwide.
Source: https://news.gbimonthly.com/tw/article/show.php?num=78517
